History

Arrayjet Ltd was founded in August 2000 by a Cambridge physicist, Dr. Howard Manning, and University of Edinburgh molecular biologists, Prof. Peter Ghazal and Dr. Douglas Roy, to develop robotics using inkjet printheads to make biological microarrays. In February 2001 Arrayjet secured two-stage funding from the Scotland based investor group known as Archangels and won a Scottish Enterprise SMART award to develop the ink jet microarray platform. Further funding by Archangels and SE followed.

Dr. Manning is Arrayjet's Technical Director and Keith Howell, an Edinburgh based director and consultant, is Chairman. From February 2001 to summer 2005 a team of 5 engineers developed the fundamental technology, additional funding was secured, and the first pre-production instruments developed and validated with commercial partners. Since 2005 the original engineering and technical team of 5 has expanded alongside Arrayjet’s engineering and laboratory facilities to meet the increasing demand for development and manufacturing.

Arrayjet has now established a number of products in the microarray market, including the newly launched Ultra-Marathon,has an expanding client base in the US and Europe, and continues to develop its patented technology.

ARRAYJET is not licensed under any patents owned by Oxford Gene Technology Limited or related companies ("OGT") and cannot pass any such licence to its customers. A licence under OGT’s patents may be necessary to manufacture or use oligonucleotide arrays.

History • Partners • People